Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
07 December 2017Website:
http://www.quanterix.comNext earnings report:
27 February 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | 4 min agoDividend
Analysts recommendations
Institutional Ownership
QTRX Latest News
LOS ANGELES, CA / ACCESSWIRE / November 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK , Nov. 21, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that is investigating potential claims against Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX) on behalf of Quanterix stockholders. The investigation concerns whether Quanterix and certain of its officers and/or directors have engaged in securities fraud.
NEW YORK CITY, NY / ACCESSWIRE / November 20, 2024 / PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that is investigating potential claims against Quanterix Corporation ("Quanterix" or the "Company")( NASDAQ:QTRX) on behalf of Quanterix stockholders. The investigation concerns whether Quanterix and certain of its officers and/or directors have engaged in securities fraud.
NEW YORK, NY / ACCESSWIRE / November 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Quanterix Corporation ("Quanterix Corporation") (NASDAQ:QTRX) concerning possible violations of federal securities laws. After the market closed, on November 12, 2024, Quanterix announced that it had "identified an error regarding the capitalization of labor and overhead costs applied to prior periods, dating back to at least 2021," which had affected the valuation of its inventory.
NEW YORK, NY / ACCESSWIRE / November 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Quanterix Corporation ("Quanterix Corporation") (NASDAQ:QTRX) concerning possible violations of federal securities laws. After the market closed, on November 12, 2024, Quanterix announced that it had "identified an error regarding the capitalization of labor and overhead costs applied to prior periods, dating back to at least 2021," which had affected the valuation of its inventory.
LOS ANGELES, CA / ACCESSWIRE / November 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX). Investors who purchased Quanterix securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/QTRX.
LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Girard Sharp, LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of Qaunterix Corporation (NASDAQ: QTRX) investors.
NEW YORK, NY / ACCESSWIRE / November 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Quanterix Corporation ("Quanterix Corporation") (NASDAQ:QTRX) concerning possible violations of federal securities laws. After the market closed, on November 12, 2024, Quanterix announced that it had "identified an error regarding the capitalization of labor and overhead costs applied to prior periods, dating back to at least 2021," which had affected the valuation of its inventory.
What type of business is Quanterix?
Quanterix Corporation develops an ultra-sensitive platform for digital immunoassay and tools for medical-biological research and diagnostics. The company offers a single molecule platform (Simoa) that uses single molecule measurements to detect protein biomarkers. The company also focuses on implementing and developing new treatment and diagnostic methods, making medical services easier for early detection, monitoring, prognosis, and ultimately disease prevention. Simoa specializes in research and clinical trials and significantly advances the enzyme-linked immunosorbent assay (ELISA) technology, providing unprecedented sensitivity in protein detection. Quanterix Corporation was founded in 2007, with its headquarters located in Billerica, Massachusetts.
What sector is Quanterix in?
Quanterix is in the Healthcare sector
What industry is Quanterix in?
Quanterix is in the Medical Devices industry
What country is Quanterix from?
Quanterix is headquartered in United States
When did Quanterix go public?
Quanterix initial public offering (IPO) was on 07 December 2017
What is Quanterix website?
https://www.quanterix.com
Is Quanterix in the S&P 500?
No, Quanterix is not included in the S&P 500 index
Is Quanterix in the NASDAQ 100?
No, Quanterix is not included in the NASDAQ 100 index
Is Quanterix in the Dow Jones?
No, Quanterix is not included in the Dow Jones index
When was Quanterix the previous earnings report?
No data
When does Quanterix earnings report?
The next expected earnings date for Quanterix is 27 February 2025